Dr Mikyung Kelly Seo
Position: Research Associate
Personal home page:
PubMed journal articles - click here
Symplectic Elements feed provided by Research Information, University of Cambridge
Seo, Mikyung Kelly. "Has the development of cancer biomarkers to guide treatment improved health outcomes?." The European Journal of Health Economics (2021): 1-22.
Seo, Mikyung Kelly, et al. "HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?." PharmacoEconomics-open 4.3 (2020): 529-539.
Seo, Mikyung Kelly, and John Cairns. "Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer." PloS one 13.9 (2018): e0204496.
Seo, Mikyung Kelly, Peter Baker, and Karen Ngoc-Lan Ngo. "Cost-effectiveness analysis of vaccinating children in Malawi with RTS, S vaccines in comparison with long-lasting insecticide-treated nets." Malaria Journal 13.1 (2014): 1-11.
Blanchard, A., and R. Strand, M.K. Seo, et al. "Cancer biomarkers: Ethics, economics and society." (2017). DOI: 10.24994/2018/b.biomarkers
Micocci M, Gordon AL, Seo MK, et al. "Is Point-of-Care testing feasible and safe in care homes in England? An exploratory usability and accuracy evaluation of a Point-of-Care Polymerase Chain Reaction test for SARS-COV-2." Age Ageing. 2021 Apr 21:afab072. DOI: 10.1093/ageing/afab072. PMID: 33884411; PMCID: PMC8083194.